23:26 , Nov 13, 2018 |  BC Extra  |  Company News

Management tracks: Anchiano, ContraFect

Cancer company Anchiano Therapeutics Inc. (Tel Aviv:ANCN) appointed Stephen Hoffman chairman. He is CEO of Aerpio Pharmaceuticals Inc. (OTCQB:ARPO). Anchiano also named Robert Connelly a director. He was a venture partner at Flagship Pioneering and...
18:30 , Nov 9, 2018 |  BC Week In Review  |  Financial News

Cabaletta spins out of Penn with CAR T autoimmune therapy, $38M series A

University of Pennsylvania spinout Cabaletta Bio Inc. (Radnor, Pa.) emerged from stealth with an untranched $38 million series A to develop CAR T therapies for B cell-mediated autoimmune diseases. Cabaletta's co-founders include Michael Milone, an...
20:09 , Nov 8, 2018 |  BC Extra  |  Financial News

Cabaletta spins out of Penn with CAR T autoimmune therapy, $38M series A

University of Pennsylvania spinout Cabaletta Bio Inc. (Radnor, Pa.) emerged from stealth with an untranched $38 million series A to develop CAR T therapies for B cell-mediated autoimmune diseases. Cabaletta's co-founders include Michael Milone, an...
17:59 , Oct 12, 2018 |  BC Week In Review  |  Financial News

5AM looking for $350M sixth fund

5AM Ventures aims to raise $350 million for its sixth fund, according to an Oct. 8 SEC filing. The firm raised $285 million for its fifth fund, which closed in May 2016. 5AM led or...
20:40 , Oct 8, 2018 |  BC Extra  |  Financial News

5AM looking for $350M sixth fund

5AM Ventures aims to raise $350 million for its sixth fund, according to an SEC filing. The firm raised $285 million for its fifth fund, which closed in May 2016. 5AM led or co-led recent...
16:33 , Sep 21, 2018 |  BC Week In Review  |  Financial News

Biodesy raises $20M in series C, appoints new CEO

Biodesy Inc. (South San Francisco, Calif.) raised $20 million Sept. 10 in a series C round led by new investor Alexandria Venture Investments. Existing investors 5AM Ventures, Pfizer Ventures and Roche Venture Fund also participated...
18:31 , Aug 31, 2018 |  BC Week In Review  |  Financial News

Arvinas looking to raise $100M in IPO

Protein degradation company Arvinas LLC (New Haven, Conn.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, Citigroup and Piper Jaffray. Arvinas is developing small molecules based on...
19:59 , Aug 30, 2018 |  BC Extra  |  Financial News

Arvinas looking to raise $100M in IPO

Protein degradation company Arvinas LLC (New Haven, Conn.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, Citigroup and Piper Jaffray. Arvinas is developing small molecules based on...
19:51 , Aug 10, 2018 |  BioCentury  |  Finance

Sound story

Preclinical data supporting Akouos Inc.’s hearing loss program convinced 5AM Ventures to re-up for a $50 million series A round, and those funds plus additions to the Akouos team have the company poised to take...
18:40 , Aug 10, 2018 |  BC Week In Review  |  Financial News

Hearing loss play Akouos grabs $50M series A

Akouos Inc. (Boston, Mass.) raised $50 million on Aug. 7 in a series A round co-led by existing investors 5AM Ventures and New Enterprise Associates. Partners Innovation Fund and new investors Sofinnova Ventures, RA Capital...